Neurology
1 drug is in development for Idiopathic Inflammatory Myopathies.
- Companies
- 1
- Clinical trials
- 9
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Idiopathic Inflammatory Myopathies pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| nkx019 | Nkarta, Inc. (NKTX) |
About this indication
Idiopathic Inflammatory Myopathies context
Neurology·MeSH: Myositis (D009220)
Narrower concept of MeSH descriptor Myositis
Frequently asked questions
How many drugs are in development for Idiopathic Inflammatory Myopathies?
BioSniper tracks 1 drug in development for Idiopathic Inflammatory Myopathies across 1 company.
How many clinical trials target Idiopathic Inflammatory Myopathies?
There are 9 clinical trials targeting Idiopathic Inflammatory Myopathies tracked by BioSniper.